Trial Profile
Effects of varenicline and cognitive bias modification on neural response to smoking-related cues
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Nov 2018
Price :
$35
*
At a glance
- Drugs Varenicline (Primary)
- Indications Smoking withdrawal
- Focus Pharmacodynamics
- Sponsors Pfizer
- 10 Feb 2014 New trial record